SEQ Medical assessment
- Risk rating
- High
- Comments
- Waterborne parasite. Indicates serious contamination concern if confirmed.
- Suggested action
- Urgent investigation. Waterborne parasite in a healthcare water context — review source water, filtration and the contamination pathway, and escalate through the infection-control pathway.
Giardia intestinalis is a flagellated protozoan parasite of the small intestine and the cause of giardiasis. The organism is also referred to in the literature as Giardia duodenalis and Giardia lamblia; the three names denote the same species and are used interchangeably. The life cycle comprises a motile, adherent trophozoite that colonises the proximal small bowel and an environmentally stable cyst that is shed in faeces. Molecular typing divides the species into assemblages, of which assemblages A and B account for human infection while others are largely host-restricted to animals.
The cyst is the stage that matters for water quality. It measures roughly eight to twelve micrometres by seven to ten micrometres, is excreted already infectious, and remains viable in cool surface water for weeks to months. Because it is somewhat larger than a Cryptosporidium oocyst, it is marginally easier to remove by filtration, though the difference is not large enough to justify different filter specification in practice. Trophozoites, by contrast, are fragile, do not survive outside the host, and play no part in environmental transmission; only the cyst is relevant to a water sample.
Giardiasis is among the most commonly reported enteric parasitic infections worldwide and is notifiable in Australian jurisdictions. Clinical presentation ranges from asymptomatic carriage to acute or persistent diarrhoea with bloating, flatulence, abdominal discomfort, steatorrhoea and weight loss. Malabsorption and lactose intolerance may follow and can persist after the parasite has been cleared. Chronic or recurrent infection in young children is associated with impaired growth and nutritional status.
A feature of clinical importance is that a substantial proportion of infections are asymptomatic, and asymptomatic carriers shed cysts and contribute to onward transmission. This is relevant both to outbreak investigation, where the case count identified through symptomatic presentation understates the true extent, and to healthcare settings, where patients presenting for gastrointestinal investigation may be shedding cysts without a diagnosis having been made or suspected.
Associated infections
- Giardiasis, acute and chronic diarrhoeal disease
- Malabsorption syndrome and steatorrhoea
- Secondary lactose intolerance
- Failure to thrive and growth faltering in children
- Post-infectious irritable bowel syndrome
- Chronic fatigue and persistent symptoms following clearance
- Asymptomatic cyst carriage
Transmission route
Transmission is faecal-oral. Waterborne transmission is the dominant route, and reviews of documented outbreaks attribute the large majority to drinking water, with a further substantial proportion to recreational water; food-borne transmission and direct person-to-person spread in households, childcare centres and among men who have sex with men also occur. The public health significance of the cyst rests on two properties: it is immediately infectious on excretion and can remain viable in surface water for months, and the infectious dose is very low, with as few as ten cysts capable of establishing infection.
That combination is what makes small breaches consequential. A contamination event that introduces a numerically trivial quantity of faecal material can deliver an infectious dose, which is why waterborne giardiasis outbreaks are frequently traced to intermittent or transient failures such as a pressure loss event, a cross-connection, an unfiltered or inadequately filtered surface supply, or contamination of a rainwater or bore source, rather than to a chronic treatment deficiency. Recreational water transmission follows the same logic in chlorinated pools, where a faecal accident introduces cysts that the maintained residual will not promptly inactivate.
Giardia cysts are resistant to the levels of free chlorine routinely maintained in drinking water distribution, which is why chlorination alone is not regarded as adequate protection and why filtration, catchment protection and, increasingly, ultraviolet disinfection are relied upon. Comparative work indicates that Giardia is nevertheless appreciably more susceptible to both chlorine and ultraviolet irradiation than Cryptosporidium, becoming non-viable at ultraviolet doses of roughly 20 mJ per square centimetre.
Giardia has no role as a coloniser of healthcare water systems and does not participate in pipe biofilm. It is not an organism that establishes itself within a purified water loop or a washer-disinfector. Detection of Giardia in a healthcare water sample is therefore not a biofilm or reprocessing finding but an indicator of faecal contamination of the supply or of the internal distribution system, and should be escalated to the facility water safety group and the relevant public health unit. Its practical connection to endoscope reprocessing is confined to bioburden: cysts may be present in faecal material on colonoscopes and are unlikely to be inactivated by chlorine-based agents, which underscores the requirement for complete manual cleaning before high-level disinfection.
Relevance in endoscopy and reprocessing
Giardia does not colonise endoscope channels, does not form or participate in biofilm, and cannot replicate outside a host. There is no established record of endoscope-transmitted giardiasis, and the organism is not among those that routine reprocessing surveillance is designed to detect. A facility should not expect to encounter it in channel samples, and its appearance in one would raise the same questions as its appearance in a water sample.
The relevant exposure is bioburden on lower gastrointestinal instruments. Patients undergoing colonoscopy for investigation of chronic diarrhoea, malabsorption or unexplained weight loss include some proportion who are shedding Giardia cysts, often without a parasitological diagnosis having been made, and asymptomatic carriers add further to that number. Faecal material entering scope channels will carry cysts in those patients. The control is manual cleaning, which physically removes the cysts with the soil, and this is where the emphasis belongs. Relying on the high-level disinfection step to compensate is less sound than it is for vegetative organisms, because protozoan cysts are more resistant to chemical inactivation than bacteria and yeasts and because faecal material shields them and exerts chemical demand. The high-level disinfectants used in endoscope reprocessing do have activity against protozoan cysts at label conditions, but that activity presupposes contact, and retained soil prevents it.
For CSD and dental water, the organism enters consideration only through faecal contamination of the supply. Drying and storage practices, which are central to controlling water-associated bacteria and yeasts, are irrelevant here because the cyst does not multiply and a dry surface offers it no advantage or disadvantage of consequence. What matters is the integrity of the incoming supply and the internal distribution: whether the facility draws on any non-mains source, whether backflow prevention is in place and tested, whether recent works or pressure events could have permitted ingress, and whether filtration rated for cyst removal is installed and maintained where the risk assessment calls for it.
Interpreting a detection
A Giardia detection in a healthcare water or final-rinse sample is a significant finding with real operational weight, because this is a genuine waterborne pathogen with a documented outbreak record and a very low infectious dose. It is not, however, a biofilm finding or a reprocessing hygiene finding. The cyst cannot multiply in a water system, so its presence has only one meaning: faecal material has entered the water somewhere upstream of the sampling point. Every line of investigation should follow from that.
As with Cryptosporidium, the most important message to convey is that a satisfactory chlorine residual provides no reassurance. Giardia cysts tolerate the free chlorine residuals maintained in distribution, and although they are appreciably less resistant than Cryptosporidium oocysts, they are not reliably inactivated by the contact times and concentrations that a building distribution system delivers. A compliant chlorine reading alongside a positive cyst result is entirely expected and should not be used to discount the parasitology. The low infectious dose compounds this: a count that would be regarded as trivially low for a bacterial indicator organism can represent a genuine infectious risk for Giardia.
First checks address the contamination pathway rather than the reprocessing cycle. Establish the water source and whether any recent event could have compromised it, including mains incidents, pressure loss or main breaks, heavy rainfall affecting a catchment or rainwater tank, works on the internal distribution, and any cross-connection or backflow risk from non-potable, recycled or fire-service water on site. Confirm whether any non-mains supply is in use. Verify the specification, integrity and change status of filtration intended to provide a cyst barrier. Confirm the sample matrix and analytical method with the laboratory and exclude cross-contamination with a clinical faecal specimen, particularly where the laboratory processes both clinical and environmental samples; this is a realistic alternative explanation and should be excluded before a major response is committed.
Escalation for a confirmed result is immediate and does not require a trend or a repeat. Notify the facility water safety group, infection prevention, facility executive and the relevant state or territory public health unit, together with the water utility where a mains source is implicated. Pending investigation, use of the implicated water for final rinse and for any patient-contact purpose should be suspended and an alternative validated source substituted, and recent procedures should be reviewed for potential patient exposure. Giardiasis is notifiable in Australian jurisdictions, so any linked clinical case carries its own reporting obligation. A single unconfirmed result should be verified urgently rather than dismissed, given the low infectious dose and the seriousness of what a true positive implies.
Antimicrobial resistance
Giardia cysts tolerate the free chlorine residuals used in routine drinking water distribution, although they are less resistant than Cryptosporidium oocysts and are effectively inactivated by adequate ultraviolet doses, by ozone, and removed by filtration. The comparative position is worth stating precisely, because the two parasites are often grouped together in facility risk assessments as though they behaved identically. Giardia is meaningfully more susceptible to chlorine and can be inactivated at Ct values that are high but not unattainable in engineered treatment, whereas Cryptosporidium is effectively refractory. Both are readily inactivated by ultraviolet irradiation at practical doses, with Giardia rendered non-viable at around 20 mJ per square centimetre, and both are removed by appropriately rated filtration.
The practical implication for a healthcare facility is the same in either case: a chlorine-based control strategy is not a protozoan barrier, and where the risk assessment identifies a credible faecal contamination pathway, the barrier must be physical or ultraviolet. Filtration must be rated for absolute removal below the cyst size, integrity-tested and changed on schedule, and ultraviolet systems must have verified dose delivery accounting for lamp age, sleeve fouling and water transmissivity. An installed but unmonitored ultraviolet unit does not constitute a barrier.
Clinically, first-line treatment is with nitroimidazoles, principally metronidazole or tinidazole. Treatment failure occurs in a minority of patients and may reflect reinfection, inadequate adherence, or genuine drug resistance; nitroimidazole-refractory giardiasis is increasingly reported and is generally managed with an alternative agent such as albendazole, nitazoxanide, paromomycin or quinacrine, or with combination therapy. Where a case is linked to a healthcare water exposure, the possibility of continuing exposure should be considered before apparent treatment failure is attributed to drug resistance, since reinfection from an unremediated source presents identically.
Sources and further reading
- United States Environmental Protection Agency. Giardia: Drinking Water Health Advisory. https://www.epa.gov/sites/default/files/2015-10/documents/giardia-report.pdf
- Adeyemo FE, Singh G, Reddy P, Bux F, Stenstrom TA. Efficiency of chlorine and UV in the inactivation of Cryptosporidium and Giardia in wastewater. PLOS ONE. 2019;14(5):e0216040. doi:10.1371/journal.pone.0216040
- Global Water Pathogen Project. Giardia duodenalis.
